Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Direkt zur Navigaton springen.
Direkt zum Inhalt springen.

Navigation/Suche

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid Stoffw Microb

Adebahr, S; Schimek-Jasch, T; Nestle, U; Brunner, TB.
Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies.
Best Pract Res Clin Gastroenterol. 2016; 30(4):565-80 Doi: 10.1016/j.bpg.2016.07.003
Web of Science PubMed FullText FullText_MUG

Co-Autor*innen der Med Uni Graz: Brunner Thomas Baptist
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: The oesophagus as a serial organ located in the central chest is frequent subject to "incidental" dose application in radiotherapy for several thoracic malignancies including oesophageal cancer itself. Especially due to the radiosensitive mucosa severe radiotherapy induced sequelae can occur, acute oesophagitis and strictures as late toxicity being the most frequent side-effects. In this review we focus on oesophageal side effects derived from treatment of gastrointestinal cancer and secondly provide an overview on oesophageal toxicity from conventional and stereotactic fractionated radiotherapy to the thoracic area in general. Available data on pathogenesis, frequency, onset, and severity of oesophageal side effects are summarized. Whereas for conventional radiotherapy the associations of applied doses to certain volumes of the oesophagus are well described, the tolerance dose to the mediastinal structures for hypofractionated therapy is unknown. The review provides available attempts to predict the risk of oesophageal side effects from dosimetric parameters of SBRT.
Find related publications in this database (using NLM MeSH Indexing): Esophageal Neoplasms - radiotherapy; Esophagitis - etiology; Esophagus - radiation effects; Humans - administration & dosage; Thoracic Neoplasms - radiotherapy
Find related publications in this database (Keywords): Oesophagus toxicity; Chemoradiotherapy; Gastrointestinal cancer; Radiotherapy; Stereotactic body radiotherapy (SBRT)